Liu WD - Search Results

1

Hypogonadism among HIV-positive men who have sex with men in Taiwan: Prevalence and associated factors.

Lin KY, Sun HY, Liu WD, Lin CY, Tsai MJ, Chuang YC, Li HY, Lin JW, Liu WC, Wu PY, Chen LY, Chang HY, Luo YZ, Chen YT, Li GC, Shih SR, Hung CC. Lin KY, et al. Among authors: liu wd. J Microbiol Immunol Infect. 2024 May 24:S1684-1182(24)00083-5. doi: 10.1016/j.jmii.2024.05.006. Online ahead of print. J Microbiol Immunol Infect. 2024. PMID: 38816319 Free article.

2

Helicobacter pylori Treatment and Gastric Cancer Risk Among Individuals With High Genetic Risk for Gastric Cancer.

Xu HM, Han Y, Liu ZC, Yin ZY, Wang MY, Yu C, Ma JL, Sun D, Liu WD, Zhang Y, Zhou T, Zhang JY, Pei P, Yang L, Millwood IY, Walters RG, Chen Y, Du H, Chen Z, You WC, Li L, Pan KF, Lv J, Li WQ. Xu HM, et al. Among authors: liu wd. JAMA Netw Open. 2024 May 1;7(5):e2413708. doi: 10.1001/jamanetworkopen.2024.13708. JAMA Netw Open. 2024. PMID: 38809553 Free PMC article.

3

Mycoplasma genitalium infection and resistance-associated mutations to macrolides and fluoroquinolones among high-risk patients in Taiwan.

Tsai MJ, Sun HY, Su LH, Lin KY, Liu WD, Huang YS, Chen GJ, Su YC, Liu WC, Chang SY, Hung CC. Tsai MJ, et al. Among authors: liu wd. J Microbiol Immunol Infect. 2024 May 11:S1684-1182(24)00081-1. doi: 10.1016/j.jmii.2024.05.004. Online ahead of print. J Microbiol Immunol Infect. 2024. PMID: 38777653 Free article.

4

A Phase 3, Randomized, Controlled Trial Evaluating the Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Moderate COVID-19.

Liu WD, Feng PH, Cheng CY, Chou CL, Lee CH, Lu MC, Liu PY, Lee MH, Liao CH, Chen MC, Chen CP, Hsu SF, Tzeng YT, Lin YC, Ou TY, Qin A, Tsai CY, Shih WJ, Lee KY, Sheng WH. Liu WD, et al. Infect Dis Ther. 2024 May 21. doi: 10.1007/s40121-024-00992-5. Online ahead of print. Infect Dis Ther. 2024. PMID: 38771550

5

High-performance flexible p-type Ce-filled Fe₃CoSb₁₂ skutterudite thin film for medium-to-high-temperature applications.

Li D, Shi XL, Zhu J, Cao T, Ma X, Li M, Han Z, Feng Z, Chen Y, Wang J, Liu WD, Zhong H, Li S, Chen ZG. Li D, et al. Among authors: liu wd. Nat Commun. 2024 May 18;15(1):4242. doi: 10.1038/s41467-024-48677-4. Nat Commun. 2024. PMID: 38762562 Free PMC article.

6

LbSakA-mediated phosphorylation of the scaffolding protein LbNoxR in the ectomycorrhizal basidiomycete Laccaria bicolor regulates NADPH oxidase activity, ROS accumulation and symbiosis development.

Shi L, Wang Z, Chen JH, Qiu H, Liu WD, Zhang XY, Martin FM, Zhao MW. Shi L, et al. Among authors: liu wd. New Phytol. 2024 May 13. doi: 10.1111/nph.19813. Online ahead of print. New Phytol. 2024. PMID: 38741469

7

Boosting thermoelectric performance of single-walled carbon nanotubes-based films through rational triple treatments.

Liu YM, Shi XL, Wu T, Wu H, Mao Y, Cao T, Wang DZ, Liu WD, Li M, Liu Q, Chen ZG. Liu YM, et al. Among authors: liu wd. Nat Commun. 2024 Apr 23;15(1):3426. doi: 10.1038/s41467-024-47417-y. Nat Commun. 2024. PMID: 38654020 Free PMC article.

8

Complete response to front-line therapies is associated with long-term survival in HIV-related lymphomas in Taiwan.

Ma WL, Liu WD, Sun HY, Sheng WH, Hsieh SM, Wu SJ, Hung CC. Ma WL, et al. Among authors: liu wd. J Microbiol Immunol Infect. 2024 Apr 6:S1684-1182(24)00070-7. doi: 10.1016/j.jmii.2024.04.001. Online ahead of print. J Microbiol Immunol Infect. 2024. PMID: 38632022 Free article.

9

Sexually transmitted coinfections among at-risk HIV-positive MSM: implications for optimal preemptive treatment.

Wu TY, Lin KY, Su LH, Sun HY, Huang YS, Liu WD, Liu WC, Chang LH, Chang SY, Hung CC. Wu TY, et al. Among authors: liu wd. Front Med (Lausanne). 2024 Mar 15;11:1328589. doi: 10.3389/fmed.2024.1328589. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38560383 Free PMC article.

10

Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients.

Wu TY, Chen PY, Wang JT, Liu WD, Chen YC, Chang SC. Wu TY, et al. Among authors: liu wd. J Antimicrob Chemother. 2024 May 2;79(5):1196-1200. doi: 10.1093/jac/dkae082. J Antimicrob Chemother. 2024. PMID: 38538154 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

394 results

Search Page